📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A four-month gatifloxacin-containing regimen for treating tuberculosis. (2014)

First Author: Merle CS

Attributed to: Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1315817

PubMed Identifier: 25337748

Publication URI: http://europepmc.org/abstract/MED/25337748

Type: Journal Article/Review

Volume: 371

Parent Publication: The New England journal of medicine

Issue: 17

ISSN: 0028-4793